Regulon

Regulon: R-1675

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
161.7665110Pr-143Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
23161 ENSG00000071189 SNX13 A0A087WUZ7
9689 ENSG00000082153 BZW1 Q7L1Q6
334 ENSG00000084234 APLP2 Q06481
3655 ENSG00000091409 ITGA6 P23229
3312 ENSG00000109971 HSPA8 A8K7Q2
10728 ENSG00000110958 PTGES3 Q15185
55825 ENSG00000115425 PECR Q9BY49
5052 ENSG00000117450 PRDX1 Q06830
6249 ENSG00000130779 CLIP1 A0A024RBR1
6272 ENSG00000134243 SORT1 Q99523
3936 ENSG00000136167 LCP1 P13796
25932 ENSG00000169504 CLIC4 Q9Y696
4973 ENSG00000173391 OLR1 A0A024RAU0
5571 ENSG00000181929 PRKAG1 P54619
4067 ENSG00000254087 LYN P07948
2342 ENSG00000257365 FNTB P49356

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
LONAFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor41
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
FORIGERIMODHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
TIPIFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor32
BOSUTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein42
BAFETINIBLYNSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
JNJ-26483327ERBB2Small moleculeINHIBITORTyrosine-protein kinase FYN inhibitor10
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
FORIGERIMOD ACETATEHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
TOLIMIDONELYNSmall moleculePOSITIVE ALLOSTERIC MODULATORTyrosine-protein kinase Lyn positive allosteric modulator20
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1675

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs